Article Image
IPFS News Link • Science, Medicine and Technology

Finally Confirmed! Vitamin D Nearly Abolishes ICU Risk in COVID-19


The First Randomized Controlled Trial on Vitamin D and COVID-19

The trial was conducted at the Reina Sofi?a University Hospital in Co?rdoba, Spain. The trial included 76 patients with COVID-19 pneumonia. Although this is no longer the standard of care, all patients were treated with hydroxychloroquine and azithromycin and, when needed, a broad-spectrum antibiotic. Admission to the ICU was determined by a multidisciplinary committee consisting of intensive care specialists, pulmonologists, internal medicine specialists, and members of the ethics committee.

The patients were randomly allocated to receive or not receive vitamin D in a 2:1 ratio. This resulted in 50 patients in the vitamin D group and 26 patients in the control group.

Free Talk Live